Fidelity Investments’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7M | Buy |
468,476
+5,597
| +1% | +$83.7K | ﹤0.01% | 2056 |
|
|
2025
Q1 | $5.42M | Sell |
462,879
-397,454
| -46% | -$4.65M | ﹤0.01% | 2115 |
|
|
2024
Q4 | $19.7M | Buy |
860,333
+128,532
| +18% | +$2.94M | ﹤0.01% | 1734 |
|
|
2024
Q3 | $30.7M | Buy |
731,801
+659,515
| +912% | +$27.7M | ﹤0.01% | 1561 |
|
|
2024
Q2 | $2.63M | Buy |
+72,286
| New | +$2.63M | ﹤0.01% | 2275 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5239 |
|
|
2022
Q2 | – | Sell |
-60
| Closed | -$2K | – | 5308 |
|
|
2022
Q1 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 4686 |
|